C

Concord Biotech Ltd
NSE:CONCORDBIO

Watchlist Manager
Concord Biotech Ltd
NSE:CONCORDBIO
Watchlist
Price: 2 019.3 INR 1.41% Market Closed
Market Cap: 211.3B INR
Have any thoughts about
Concord Biotech Ltd?
Write Note

Income Statement

Earnings Waterfall
Concord Biotech Ltd

Revenue
10.4B INR
Cost of Revenue
-2.4B INR
Gross Profit
8B INR
Operating Expenses
-4.1B INR
Operating Income
3.9B INR
Other Expenses
-737.5m INR
Net Income
3.1B INR

Income Statement
Concord Biotech Ltd

Rotate your device to view
Income Statement
Currency: INR
Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
13 103
N/A
15 511
+18%
10 169
-34%
10 379
+2%
Gross Profit
Cost of Revenue
(2 735)
(3 206)
(3 342)
(2 371)
Gross Profit
10 369
N/A
12 306
+19%
6 828
-45%
8 008
+17%
Operating Income
Operating Expenses
(5 826)
(6 839)
(3 047)
(4 139)
Selling, General & Administrative
(1 687)
(1 994)
(2 432)
(1 265)
Depreciation & Amortization
(804)
(939)
(536)
(537)
Other Operating Expenses
(3 335)
(3 906)
(79)
(2 337)
Operating Income
4 543
N/A
5 466
+20%
3 780
-31%
3 870
+2%
Pre-Tax Income
Interest Income Expense
(16)
9
245
(33)
Non-Reccuring Items
0
0
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
Total Other Income
501
583
100
374
Pre-Tax Income
5 028
N/A
6 059
+21%
4 126
-32%
4 211
+2%
Net Income
Tax Provision
(1 272)
(1 527)
(1 045)
(1 078)
Income from Continuing Operations
3 756
4 532
3 081
3 132
Net Income (Common)
3 756
N/A
4 532
+21%
3 081
-32%
3 132
+2%
EPS (Diluted)
35.9
N/A
43.28
+21%
29.45
-32%
29.95
+2%

See Also

Discover More